Latest Articles
Lotus Endometriosis Institute Announces Post-Op Recovery Plans For Endo Patients - FinancialContent
Lotus Endometriosis Institute Announces Post-Op Recovery Plans For Endo Patients FinancialContent
Published: Aug. 1, 2026, 11:55 p.m.
Alexander Sørloth 2026 • Magic Skills & Goals & Control • Atlético Madrid ᴴᴰ Endometriosis (7LCBIOHCbC) - Mshale
Alexander Sørloth 2026 • Magic Skills & Goals & Control • Atlético Madrid ᴴᴰ Endometriosis (7LCBIOHCbC) Mshale
Published: Aug. 1, 2026, 4:17 p.m.
FRESH TAKE: Endometriosis – when women are neglected and not believed - Donegal News
FRESH TAKE: Endometriosis – when women are neglected and not believed Donegal News
Published: Aug. 1, 2026, 10:52 a.m.
Karyopharm (KPTI) Shares Collapse 65% After Xpovio Fails Endometrial Cancer Trial Again - londoninsider.co.uk
Karyopharm (KPTI) Shares Collapse 65% After Xpovio Fails Endometrial Cancer Trial Again londoninsider.co.uk
Published: Aug. 1, 2026, 8:33 a.m.
Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial - The Clinical Trial Vanguard
Karyopharm’s selinexor misses primary endpoint in Phase 3 endometrial cancer trial The Clinical Trial Vanguard
Published: Aug. 1, 2026, 6:33 a.m.
Reliability and validity of the 30-second chair-stand test for assessing functional capacity in women with endometriosis: a cross-sectional and longitudinal study.
and Hypothesis: Endometriosis often causes pelvic pain, limiting movement and physical function. Performance-based tests are fundamental to measure functional status among these women. This study aimed to evaluate the reliability …
Published: Aug. 1, 2026, midnight
'I lost years waiting for endometriosis diagnosis' - AOL.com
'I lost years waiting for endometriosis diagnosis' AOL.com
Published: July 31, 2026, 11:18 p.m.
Karyopharm To Stick With Blood Cancers As Xpovio Flops In Endometrial Cancer - insights.citeline.com
Karyopharm To Stick With Blood Cancers As Xpovio Flops In Endometrial Cancer insights.citeline.com
Published: July 31, 2026, 8:31 p.m.
Selinexor Maintenance Misses Mark in TP53 Wild-Type Endometrial Cancer - Targeted Oncology
Selinexor Maintenance Misses Mark in TP53 Wild-Type Endometrial Cancer Targeted Oncology
Published: July 31, 2026, 8:06 p.m.
Real-World Study Supports Multi-Omic Blood Test for Endometriosis - Clinical Lab Products
Real-World Study Supports Multi-Omic Blood Test for Endometriosis Clinical Lab Products
Published: July 31, 2026, 7:35 p.m.
Link copied to clipboard!